PAR 2.38% 20.5¢ paradigm biopharmaceuticals limited..

Valuation and Targets, page-217

  1. 4,408 Posts.
    lightbulb Created with Sketch. 6946
    Even if there are real, viable and genuine competitors coming which I doubt, they are a minimum of 3 - 5 years behind us, we will have a decent window of opportunity!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.